Anixa Biosciences (NASDAQ:ANIX) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]

Related Keywords

Anixa Biosciences ,Us Bancorp ,Nasdaq ,Anixa Biosciences Company Profile ,Virtu Financial ,Anixa Biosciences Inc ,Tower Research Capital ,Free Report ,Anixa Bioscience ,Get Free Report ,Wealth Management ,Research Capital ,Anixa Biosciences Daily ,Nasdaq Anix ,Sanix ,Medical ,Reiterated Rating ,Hc Wainwright ,